Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- ChecktodayChange DetectedThe page now includes a centralized 'Locations' section listing US sites by state (California, Florida, Georgia, Indiana, Michigan, Ohio, Tennessee, Texas, Virginia) and removes the separate 'X Locations' sections; it also shows the revision tag Revision: v3.3.3.SummaryDifference0.9%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a new revision label, updating from v3.2.0 to v3.3.2, which appears to be a minor documentation or UI update. There are no evident changes to study content, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page no longer displays the notice about a lapse in government funding and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedThe update on the page is limited to Study Record Dates metadata (e.g., Last Update Posted now shown as 2025-02-04 and related QC dates); no changes were made to the core study design, eligibility criteria, outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check86 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.2%

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.